Scholar Rock Holding (SRRK) Total Liabilities (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Total Liabilities of $259.2 million in Q1 2026, up 63.27% quarter-over-quarter from $158.8 million in Q4 2025, and up 172.25% on a YoY basis from $95.2 million in Q1 2025.

Scholar Rock Holding (SRRK) Total Liabilities (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Total Liabilities history runs 10 years deep, the most recent figure standing at $259.2 million for Q1 2026.

  • In Q1 2026, Total Liabilities rose 172.25% year-over-year to $259.2 million; the TTM figure through Mar 2026 stood at $259.2 million (up 172.25% YoY), while the FY2025 annual figure was $158.8 million, up 49.39% from the prior year.
  • Total Liabilities was $259.2 million for Q1 2026 at Scholar Rock Holding, up from $158.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $259.2 million in Q1 2026 to a low of $82.4 million in Q2 2023.
  • Historically, Total Liabilities has averaged $111.3 million across 5 years, with a median of $95.2 million in 2025.
  • The sharpest annual moves came in 2022 and 2026: Total Liabilities declined 26.02% in 2022, then surged 172.25% in 2026.
  • A 5-year view of Total Liabilities shows it stood at $97.9 million in 2022, then slipped by 12.37% to $85.8 million in 2023, then increased by 23.85% to $106.3 million in 2024, then surged by 49.39% to $158.8 million in 2025, then surged by 63.27% to $259.2 million in 2026.
  • The last three Total Liabilities figures came in at $259.2 million (Q1 2026), $158.8 million (Q4 2025), and $166.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.74 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.48 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 731.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 10.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 19.51 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 943,068.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.12 Bn
9 Abivax 91.96 Bn 91.96 Bn - 137.56 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 259.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 259.24 Mn
Dec 31, 2025 158.78 Mn
Sep 30, 2025 166.72 Mn
Jun 30, 2025 106.75 Mn
Mar 31, 2025 95.22 Mn
Dec 31, 2024 106.29 Mn
Sep 30, 2024 99.94 Mn
Jun 30, 2024 93.25 Mn
Mar 31, 2024 84.51 Mn
Dec 31, 2023 85.82 Mn
Sep 30, 2023 83.02 Mn
Jun 30, 2023 82.40 Mn
Mar 31, 2023 86.07 Mn
Dec 31, 2022 97.93 Mn
Sep 30, 2022 97.04 Mn
Jun 30, 2022 94.62 Mn
Mar 31, 2022 94.66 Mn
Dec 31, 2021 132.37 Mn
Sep 30, 2021 111.13 Mn
Jun 30, 2021 115.40 Mn